Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1493-1498

  Sjödin, Anna ^a   Ljuslinder, Ingrid ^a   Henriksson, Roger ^a   Hedman, Håkan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Lipophilin B; Mammaglobin; Proliferation; Secretoglobin

Indexed keywords

LIPOPHILIN B; MAMMAGLOBIN; MESSENGER RNA; PROTEOLIPID PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINEAGE; FEMALE; HUMANS; MIDDLE AGED; MYELIN PROTEINS; NEOPLASM PROTEINS; PROTEOLIPIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSDUCTION, GENETIC; UTEROGLOBIN;

EID: 45949096665     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Klug J, Beier HM, Bernard A, Chilton BS, Fleming TP, Lehrer RI, Miele L, Pattabiraman N and Singh G: Uteroglobin/Clara cell 10-kDa family of proteins: nomenclature committee report. Ann NY Acad Sci 923: 348-354, 2000.
2. Watson MA and Fleming TP: Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54: 4598-4602, 1994.
3. Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, Fleming TP, Reed SG, Houghton RL, Diamond DL and Vedvick TS: Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 41: 6714-6722, 2002.
4. Colpitts TL, Billing-Medel P, Friedman P, Granados EN, Hayden M, Hodges S, Menhart N, Roberts L, Russell J and Stroupe SD: Mammaglobin is found in breast tissue as a complex with bu 101. Biochemistry 40: 11048-11059, 2001.
5. Leygue E, Snell L, Dotzlaw H, Hole K, Troup S, Hiller-Hitchcock T, Murphy LC and Watson PH: Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol 189: 28-33, 1999.
6. Zehentner BK and Carter D: Mammaglobin: a candidate diagnostic marker for breast cancer. Clin Biochem 37: 249-257, 2004.
7. Carter D, Dillon DC, Reynolds LD, Retter MW, Fanger G, Molesh DA, Sleath PR, McNeill PD, Vedvick TS, Reed SG, Persing DH and Houghton RL: Serum antibodies to lipophilin B detected in late stage breast cancer patients. Clin Cancer Res 9: 749-754, 2003.
8. Goedegebuure PS, Watson MA, Viehl CT and Fleming TP: Mammaglobin-based strategies for treatment of breast cancer. Current cancer drug targets 4: 531-542, 2004.
9. Culleton J, O'Brien N, Ryan BM, Hill AD, McDermott E, O'Higgins N and Duffy M J: Lipophilin B: A gene preferentially expressed in breast tissue and upregulated in breast cancer. Int J Cancer 120: 1087-1092, 2007.
10. Houghton RL, Dillon DC, Molesh DA, Zehentner BK, Xu J, Jiang J, Schmidt C, Frudakis A, Repasky E, Maltez Filho A, Nolasco M, Badaro R, Zhang X, Roche PC, Persing DH and Reed SG: Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol Diagn 6: 79-91, 2001.
11. O'Brien N, Maguire TM, O'Donovan N, Lynch N, Hill AD, McDermott E, O'Higgins N and Duffy MJ: Mammaglobin a: a promising marker for breast cancer. Clin Chem 48: 1362-1364, 2002.
12. Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R and Fleming TP: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59: 3028-3031, 1999.
13. Watson MA and Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56: 860-865, 1996.
14. Zafrakas M, Petschke B, Donner A, Fritzsche F, Kristiansen G, Rnuchel R and Dahl E: Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies. BMC Cancer 6: 88, 2006.
15. Sjodin A, Guo D, Hofer PA, Henriksson R and Hedman H: Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol 121: 428-429, 2003.
16. Sjodin A, Guo D, Lund-Johansen M, Krossnes BK, Lilleng P, Henriksson R and Hedman H: Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas. Acta Neuropathol (Berl) 109: 381-386, 2005.
17. Broers JL, Jensen SM, Travis WD, Pass H, Whitsett JA, Singh G, Katyal SL, Gazdar AF, Minna JD and Linnoila RI: Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest 66: 337-346, 1992.
18. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, Staehler G, Kretzler M, Hollstein M and Grone HJ: Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Amer J Pathol 160: 2169-2180, 2002.
19. Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J and Polyak K: Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res 2: 489-494, 2004.
20. Marchetti A, Barassi F, Martella C, Chella A, Salvatore S, Castrataro A, Mucilli F, Sacco R and Buttitta F: Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. Clin Cancer Res 10: 1338-1343, 2004.
21. Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N and Gazdar AF: Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer 113: 600-604, 2005.
22. Singh G, Singh J, Katyal SL, Brown WE, Kramps JA, Paradis IL, Dauber JH, Macpherson TA and Squeglia N: Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem 36: 73-80, 1988.
23. Weeraratna AT, Cajigas JA, Schwartz A, Enquist EG, Manyak MJ and Patierno SR: Loss of uteroglobin expression in prostate cancer: relationship to advancing grade. Clin Cancer Res 3: 2295-2300, 1997.
24. Wong TS, Kwong DL, Sham JS, Tsao SW, Wei WI, Kwong YL and Yuen AP: Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. Clin Cancer Res 9: 3042-3046, 2003.
25. Page DL, Ellis IO and Elston CW: Histologic grading of breast cancer. Let's do it. Americ J Clinic Pathol 103: 123-124, 1995.
26. Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL and Gardner MB: Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Nat Cancer Inst 58: 1795-1806, 1977.
27. Kitamura T: New experimental approaches in retrovirus-mediated expression screening. Internat J hematol 67: 351-359, 1998.
28. Sjodin A, Guo D, Sorhaug S, Bjermer L, Henriksson R and Hedman H: Dysregulated secretoglobin expression in human lung cancers. Lung Cancer 41: 49-56, 2003.
29. Gunnarsson C, Ahnstrom M, Kirschner K, Olsson B, Nordenskjold B, Rutqvist LE, Skoog L and Stal O: Amplification of HSD17B1 and ERBB2 in primary breast cancer. Oncogene 22: 34-40, 2003.
30. Belibasakis G, Johansson A, Wang Y, Claesson R, Chen C, Asikainen S and Kalfas S: Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Europ J Oral Sciences 110: 366-373, 2002.
31. Wroblewski F and Ladue JS: Lactic dehydrogenase activity in blood. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York, NY 90: 210-213, 1955.
32. Nunez-Villar MJ, Martinez-Arribas F, Pollan M, Lucas AR, Sanchez J, Tejerina A and Schneider J: Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Res 5: R65-70, 2003.
33. Span PN, Waanders E, Manders P, Heuvel JJ, Foekens JA, Watson MA, Beex LV and Sweep FC: Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol 22: 691-698, 2004.